Pharmaceuticals and life sciences

Consult us
 
Simon Friend
Global leader
Pharmaceuticals & life sciences
Tel: +44 (20) 7213 4875
See full profile
 
Mike Swanick
Global tax leader
Pharmaceuticals & life sciences
Tel: +1 (267) 330 6060
See full profile
 
Dr. Steve Arlington
Global advisory leader
Pharmaceuticals & life sciences
Tel: +44 (20) 7804 3997
See full profile
 
 

Highlights

Pharma 2020: Marketing the future

This paper discusses how the industry is no longer being rewarded for incremental innovation, me-too products and selling the most pills. Companies need to add value to patients, and offer a package of products and health services that the market is willing to pay a premium for.

Read more

Global pharma looks to India: Prospects for growth

Our report highlights that India now has a growing and increasingly sophisticated pharmaceutical industry of its own. It is likely to become a competitor of global pharma in some key areas, and a potential partner in others.

Read more

California Biomedical Industry - 2010 Report

The 2010 report on California's biomedical industry report is a collaborative effort between the California Healthcare Institute and PricewaterhouseCoopers. It offers a comprehensive overview of the impact of the biomedical sector on California's economy.

Read more

Pharma 2020: Taxing times ahead - Which path will you take?

This paper discusses how the political, economic, scientific and social trends currently shaping the commercial environment, together with the development of new, more collaborative business models, will exert increasing pressure on effective tax rates within the industry.

Read more